Two Sigma Investments
XLRN

Two Sigma Investments’s Acceleron Pharma XLRN Stock Holding History

Two Sigma Investments’s Portfolio XLRN Stock Details XLRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-54,071
Closed -$6.08M – 3916
2020
Q3 		$6.08M Sell
54,071
-145,147
-73% -$14.4M 0.02% 718
2020
Q2 		$19M Buy
199,218
+77,352
+63% +$7.46M 0.09% 226
2020
Q1 		$11M Buy
+121,866
New +$9.47M 0.09% 236
2019
Q4 		– Sell
-57,257
Closed -$2.26M – 4106
2019
Q3 		$2.26M Sell
57,257
-122,645
-68% -$5.32M 0.01% 1338
2019
Q2 		$7.39M Buy
179,902
+60,215
+50% +$2.49M 0.02% 727
2019
Q1 		$5.57M Buy
+119,687
New +$5.25M 0.02% 908
2018
Q3 		– Sell
-47,435
Closed -$2.3M – 3747
2018
Q2 		$2.3M Buy
+47,435
New +$1.73M 0.01% 1517
2018
Q1 		– Sell
-38,121
Closed -$1.62M – 3661
2017
Q4 		$1.62M Buy
+38,121
New +$1.43M 0.01% 1624
2016
Q1 		– Sell
-6,400
Closed -$312K – 3231
2015
Q4 		$312K Buy
+6,400
New +$230K ﹤0.01% 2225
2014
Q3 		– Sell
-8,089
Closed -$275K – 2155
2014
Q2 		$275K Sell
8,089
-15,075
-65% -$504K ﹤0.01% 1873
2014
Q1 		$799K Buy
+23,164
New +$1.05M ﹤0.01% 1299

Other funds holding XLRN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Two Sigma Investments's XLRN Position: Q4 2020 in Review

Two Sigma Investments sold out of Acceleron Pharma (XLRN) in Q4 2020, closing a stake of 54,071 shares — an estimated $6.08M sold.

Two Sigma Investments first reported a position in XLRN in Q1 2014 and held it in 11 quarters. The position peaked at $19M in Q2 2020. 253 funds tracked by Wall St. Rank hold XLRN as of Q4 2020.

  • Two Sigma Investments reported no remaining Acceleron Pharma position as of Q4 2020 after selling out during the quarter.
  • Two Sigma Investments sold 54,071 Acceleron Pharma shares in Q4 2020, an estimated $6.08M.
  • Two Sigma Investments first reported a position in Acceleron Pharma in Q1 2014 and held it in 11 quarters.
  • Two Sigma Investments's Acceleron Pharma position peaked at $19M in Q2 2020.
  • 253 funds tracked by Wall St. Rank held Acceleron Pharma as of Q4 2020.

Based on Two Sigma Investments's 13F filing for Q4 2020, filed 16 Feb 2021.